403 related articles for article (PubMed ID: 17213520)
1. Correlation between methotrexate efficacy & toxicity with C677T polymorphism of the methylenetetrahydrofolate gene in rheumatoid arthritis patients on folate supplementation.
Aggarwal P; Naik S; Mishra KP; Aggarwal A; Misra R
Indian J Med Res; 2006 Nov; 124(5):521-6. PubMed ID: 17213520
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis.
Kumagai K; Hiyama K; Oyama T; Maeda H; Kohno N
Int J Mol Med; 2003 May; 11(5):593-600. PubMed ID: 12684695
[TBL] [Abstract][Full Text] [Related]
3. The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population.
Cáliz R; del Amo J; Balsa A; Blanco F; Silva L; Sanmarti R; Martínez FG; Collado MD; Ramirez Mdel C; Tejedor D; Artieda M; Pascual-Salcedo D; Oreiro N; Andreu JL; Graell E; Simon L; Martínez A; Mulero J
Scand J Rheumatol; 2012 Feb; 41(1):10-4. PubMed ID: 22044028
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene.
Berkun Y; Levartovsky D; Rubinow A; Orbach H; Aamar S; Grenader T; Abou Atta I; Mevorach D; Friedman G; Ben-Yehuda A
Ann Rheum Dis; 2004 Oct; 63(10):1227-31. PubMed ID: 15361376
[TBL] [Abstract][Full Text] [Related]
6. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.
Schmeling H; Biber D; Heins S; Horneff G
J Rheumatol; 2005 Sep; 32(9):1832-6. PubMed ID: 16142884
[TBL] [Abstract][Full Text] [Related]
7. 677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis.
Kurzawski M; Pawlik A; Safranow K; Herczynska M; Drozdzik M
Pharmacogenomics; 2007 Nov; 8(11):1551-9. PubMed ID: 18034620
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of MTHFR polymorphism screening by polymerase chain reaction in Korean patients with rheumatoid arthritis receiving methotrexate.
Kim SK; Jun JB; El-Sohemy A; Bae SC
J Rheumatol; 2006 Jul; 33(7):1266-74. PubMed ID: 16758511
[TBL] [Abstract][Full Text] [Related]
9. Methylene tetrahydrofolate reductase genotypes frequencies: association with toxicity and response to methotrexate in rheumatoid arthritis patients.
Saleh MM; Irshaid YM; Mustafa KN
Int J Clin Pharmacol Ther; 2015 Feb; 53(2):154-62. PubMed ID: 25492850
[TBL] [Abstract][Full Text] [Related]
10. Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients.
Taraborelli M; Andreoli L; Archetti S; Ferrari M; Cattaneo R; Tincani A
Clin Exp Rheumatol; 2009; 27(3):499-502. PubMed ID: 19604445
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
van Ede AE; Laan RF; Blom HJ; Boers GH; Haagsma CJ; Thomas CM; De Boo TM; van de Putte LB
Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
[TBL] [Abstract][Full Text] [Related]
12. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
[TBL] [Abstract][Full Text] [Related]
13. Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.
de Rotte MC; de Jong PH; Pluijm SM; Calasan MB; Barendregt PJ; van Zeben D; van der Lubbe PA; de Sonnaville PB; Lindemans J; Hazes JM; de Jonge R
Arthritis Rheum; 2013 Nov; 65(11):2803-13. PubMed ID: 24166792
[TBL] [Abstract][Full Text] [Related]
14. Association Between MTHFR C677T Polymorphism and Methotrexate Treatment Outcome in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis.
Shao W; Yuan Y; Li Y
Genet Test Mol Biomarkers; 2017 May; 21(5):275-285. PubMed ID: 28277784
[TBL] [Abstract][Full Text] [Related]
15. The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients.
van Ede AE; Laan RF; Blom HJ; Huizinga TW; Haagsma CJ; Giesendorf BA; de Boo TM; van de Putte LB
Arthritis Rheum; 2001 Nov; 44(11):2525-30. PubMed ID: 11710708
[TBL] [Abstract][Full Text] [Related]
16. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
Chaabane S; Marzouk S; Akrout R; Ben Hamad M; Achour Y; Rebai A; Keskes L; Fourati H; Bahloul Z; Maalej A
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate.
Stamp LK; Chapman PT; O'Donnell JL; Zhang M; James J; Frampton C; Barclay ML; Kennedy MA; Roberts RL
Pharmacogenet Genomics; 2010 Jun; 20(6):367-76. PubMed ID: 20386493
[TBL] [Abstract][Full Text] [Related]
18. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE
Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
[TBL] [Abstract][Full Text] [Related]
19. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients.
Soukup T; Dosedel M; Pavek P; Nekvindova J; Barvik I; Bubancova I; Bradna P; Kubena AA; Carazo AF; Veleta T; Vlcek J
Rheumatol Int; 2015 Jul; 35(7):1149-61. PubMed ID: 25618758
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis.
Plaza-Plaza JC; Aguilera M; Cañadas-Garre M; Chemello C; González-Utrilla A; Faus Dader MJ; Calleja MA
OMICS; 2012 Nov; 16(11):589-95. PubMed ID: 23095111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]